Novavax reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, its COVID-19 vaccine candidate.Novavax (NVAX) and Canada expect to finalize an advance purchase agreement under which the company will supply doses of NVX-CoV2373 as early as the second quarter of 2021. The purchase arrangement will be subject to licensure of the Novavax vaccine by Health Canada.“We are pleased to work with the Canadian government on supply of our COVID-19 vaccine, an essential step to ensure broad access of our vaccine candidate,” said Novavax CEO Stanley C. Erck. “We are moving …read more
Source:: Yahoo Finance
